Diet and Rheumatoid Arthritis: A Review of the Literature

Royal Adelaide Hospital, Tarndarnya, South Australia, Australia
Seminars in Arthritis and Rheumatism (Impact Factor: 3.63). 11/2005; 35(2):77-94. DOI: 10.1016/j.semarthrit.2005.05.001
Source: PubMed

ABSTRACT Rheumatoid arthritis is a common inflammatory condition. A large number of patients seek alternative or complementary therapies of which diet is an important component. This article reviews the evidence for diet in rheumatoid arthritis along with the associated concept of oral tolerization.
References were taken from Medline from 1966 to September 2004. The keywords, rheumatoid arthritis, diet, n-3 fatty acids, vitamins, and oral tolerization, were used.
Randomized controlled trials (RCTs) indicate that dietary supplementation with n-3 fatty acids provides modest symptomatic benefit in groups of patients with rheumatoid arthritis. Epidemiological studies and RCTs show cardiovascular benefits in the broader population and patients with ischemic heart disease. A number of mechanisms through which n-3 fats may reduce inflammation have been identified. In a small number of patients with rheumatoid arthritis, other dietary manipulation such as fasting, vegan, and elimination diets may have some benefit. However, many of these diets are impractical or difficult to sustain long term.
Dietary manipulation provides a means by which patients can a regain a sense of control over their disease. Dietary n-3 supplementation is practical and can be easily achieved with encapsulated or, less expensively, bottled fish oil.

Download full-text


Available from: Leslie Cleland, Jul 08, 2015
  • Source
    • "Rheumatoid arthritis is a systemic autoimmune illness characterized by chronic inflammation of synovial joints leading to destruction of cartilage and bone, and affects about 1% of world's total population (Borchers et al., 2004; Chunxia et al., 2011; Maini and Taylor, 2000; Sanchez-Fidalgo et al., 2010; Stamp et al., 2005). A great number of patients suffering from rheumatoid arthritis have been looking for alternative or complementary therapies of which diet is one of the most important factors. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The present study was carried out to investigate the effects of nanopowdered peanut sprout-added Caciocavallo cheese (NPCC) on the prevention and treatment of rheumatoid arthritis in DBA/IJ mice immunized with type II collagen. After the induction of arthritis, the mice were being divided into five groups: (1) normal, no immunization; (2) CIA, collagen-induced arthritis; (3) MTX, collagen-induced arthritis treated with methotrexate (0.3 mg/kg body weight); (4) CC, collagen-induced arthritis treated with Caciocavallo cheese (0.6 g/d); (5) NPCC, collagen-induced arthritis treated with nanopowdered peanut sprout-added Caciocavallo cheese (0.6 g/d). Nanopowdered peanut sprout was ranged from 300 to 350 nm, while regular powdered peanut sprouts were ranged from 50 to . The NPCC group had considerable reductions of clinical scores and paw thicknesses at the end of experiment as compared to the CIA group. In the serum analysis, the TNF-, IL-, IL-6 and levels in the NPCC group have decreased by 69.4, 75.9, 66.6, and 61.9%, respectively, when compared to the CIA group. The histological score and spleen index of the NPCC group were significantly lower than the CIA group. In conclusion, the feeding NPCC method could delay and/or prevent the rheumatoid arthritis in the collagen-induced arthritis mouse model. Based on this study, nanopowdered peanut sprouts could be applied to various functional cheeses.
    Hangug chugsan sigpum haghoeji = Korean journal for food science of animal resources 02/2014; 34(1). DOI:10.5851/kosfa.2014.34.1.49 · 0.25 Impact Factor
  • Source
    • "Sometimes fishy halitosis or fishy body odour (Cleland et al., 2003) so as nausea and moderate gastrointestinal disorder (Gissi-HF Investigators et al., 2008; Ross et al., 2007) occur. Moreover, the additionally applied dietary manipulation provides a resource enabling patients to regain the perception of controlling their disease (Stamp et al., 2005). The major barrier for a broad therapeutic use of fish oil in inflammatory diseases, though, constitutes the delayed onset of efficacy (Cleland et al., 2006) that may last up to more than three months. "
    [Show abstract] [Hide abstract]
    ABSTRACT: ABSTRACT: The n-3 polyunsaturated fatty (PUFA) acids and among them the n-3 PUFAs from fish oil – eicosapentaenoic acid and docosahexaenoic acid - own potent immunomodulatory potential. This can be beneficially utilized in cardiovascular disease or depression as well as in rheumatoid arthritis. A commonly accepted opinion about the minimum dosage to gain a therapeutic effect has not been formed yet. In order to achieve an amelioration of symptoms in RA the concluding recommendation is to consume dietary supplements containing three to six gram n-3 fatty acids daily for > 12 weeks. Following these suggestions patients taking dietary supplements of fish oil show improvements in clinical parameters including the number of tender joints, the duration of morning stiffness as well as the patient´s evaluation of global arthritis activity. Finally, the intake of n-3 PUFAs can only be recommended as an add-on therapy and must not replace the standard therapeutic regimes. A large research agenda remains to be worked on in order to be able to determine the role of therapeutic effects of n-3 PUFAs in RA. KEY WORDS: Fish oil, n-3 PUFA, n-6 PUFA, Rheumatoid arthritis
    Current Topics in Nutraceutical Research 01/2008; · 0.19 Impact Factor
  • Source
    • "They showed that 76% of patients with rheumatoid arthritis and 70% of patients with osteoarthritis benefited from Lyprinol®. It has been found that increased consumption of ω-3 PUFAs alter the generation of AA-derived inflammatory metabolites, and reduce inflammatory responses (Stamp et al., 2005). Lyprinol® has been shown to have greater AI activity than the more commonly used ω-3 PUFA-containing therapeutic oils (Whitehouse et al., 1997). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The present study has identified in the marine mollusc, Perna canaliculus, an homologous series of novel omega 3 polyunsaturated fatty acids (omega-3 PUFA) with significant anti-inflammatory (AI) activity. The free fatty acid (FFA) class was isolated from a supercritical-CO2 lipid extract of the tartaric acid-stabilised freeze-dried mussel powder by normal phase chromatography, followed by reversed-phase high performance liquid chromatography (RP-HPLC). The RP-HPLC involved separation based on carbon numbers, followed by argentation-HPLC (Ag-HPLC) of the methyl esters based on degree of unsaturation. Identification of the FFA components was performed using gas chromatography (GC) with flame ionisation detection, and individual structures were assigned by GC-mass spectroscopy (GC-MS). Inhibition of leukotriene production by stimulated human neutrophils was used as an in vitro screening method to test the AI activity of the purified PUFAs. A structurally related family of omega-3 PUFAs was identified in the most bioactive fractions, which included C18:4, C19:4, C20:4, and C21:5 PUFA. The C20:4 was the predominant PUFA in the extract, and was a structural isomer of arachidonic acid (AA). The novel compounds may be biologically significant as AI agents, as a result of their in vitro inhibition of lipoxygenase products of the AA pathway.
    Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology 09/2007; 147(4):645-56. DOI:10.1016/j.cbpb.2007.04.004 · 1.90 Impact Factor